En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Svenska Aerogel
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
Events
In Media
M&A Know-how
Macro and markets
Market Snapshots
Uncategorized
20 Feb 2023
Carlsquare Equity Research Nordic Life Science sector update
Equity Research
Abera Bioscience
23 Nov 2022
Research Update, Elicera Therapeutics: With the next clinical study in sight
Equity Research
Elicera Therapeutics
02 Jun 2022
Mrkt BUZZ Elicera: Lead Project Receives Significant Grant
Equity Research
Elicera Therapeutics
06 Apr 2022
Mrkt BUZZ Elicera: Publishing can increase awareness
Equity Research
Elicera Therapeutics
19 Jan 2022
Mrkt BUZZ Elicera: Strengthening Process and Patent Portfolio
Equity Research
Elicera Therapeutics
20 Dec 2021
Initial coverage Elicera: Cell Therapy Company Under the Radar
Equity Research
Elicera Therapeutics
